EIF1P4

Across TCGA pan-cancer cohorts, EIF1P4 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated EIF1P4 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher EIF1P4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated EIF1P4 expression acts as an unfavorable survival marker, although some lineages such as HNSC and THYM show a favorable association.

LIHC, ACC, and HNSC are the cancer types where EIF1P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.229	0.464	<.001	54	view →
ACC	OS	Tertile	All	0.115	0.752	<.001	45	view →
HNSC	DFS	Tertile	IV	0.475	0.263	.001	43	view →
UCEC	DFS	Quartile	All	0.499	0.686	.001	34	view →
GBM	DFS	Median	All	0.174	0.310	.008	27	view →
THYM	OS	Median	All	1.000	0.785	.005	23	view →
OV	DFS	Tertile	All	0.615	0.508	.014	22	view →
MESO	OS	Tertile	III,IV	0.172	0.628	.024	18	view →
SKCM	DFS	Quartile	All	0.287	0.178	.002	17	view →
PAAD	DFS	Tertile	All	0.224	0.472	.010	11	view →
DLBC	OS	Tertile	IV	0.147	1.000	.045	11	view →
CHOL	OS	Quartile	II,III,IV	0.175	0.850	.001	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

EIF1P4–LIHC (DFS)

Open the LIHC breakdown →